Stock Ratings / Consumer Discretionary / GENI

BRSL (34) PRSU (53) PRKS (48) STUB (38) ⌘ Pro Terminal →

Genius Sports Limited (GENI) — RQD Stock Rating Cockpit

$6.36 -1.55% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $6.33

Genius Sports Limited (GENI) carries a Roarable Rating of D- (Sell) with 40/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (40/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $1.73B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on GENI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is GENI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Genius Sports Limited (NYSE: GENI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 40/100 at a spot price of $6.36 (-1.55% 1D, market cap $1.73B). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 8/20. Across 1011 tracked Consumer Discretionary issuers, GENI ranks #734 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does GENI compare to BRSL and PRSU in the Consumer Discretionary sector?

▼

Within the Consumer Discretionary sector (Services-Misc. Amusement & Recreation), GENI carries a Roarable D- (40/100 RQD), trailing P/E of N/A, gross margin of 23.0%, and ROIC of -26.9%. By comparison, BRSL (Brightstar Lottery PLC Trading under the Legal Name to begin at the market open on July 21 2025.) holds a E grade (34/100 RQD, P/E 12.0x, ROIC 16.8%, cap $1.77B) and PRSU (Pursuit Attractions and Hospitality Inc.) posts a D+ grade (53/100 RQD, P/E 66.4x, ROIC 3.9%, cap $1.51B). Among the 5-stock peer group, PRKS leads on earnings multiple (8.5x) while PRKS leads on capital efficiency (17.2% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for GENI?

▼

Per GENI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001834489), Genius Sports Limited generated $669.5M in revenue (+31.0% YoY), -$111.6M in net income, and $64.5M in free cash flow against $1.13B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $6.33 (-0.47%)🧬 Disciplined Float (-0.12% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 9.6% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (40/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.4% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-8.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for GENI)Realized 20D OHLCV Swing Band: ±12.3%

Deterministic 5-Pillar Attribution (40/100 Composite)

🔍 WHY GENI SCORES 40/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+10/20 pts (25% of score)

FRED Regime × Technicals: 33% of 52W Range • RSI-14 at 50.2 (NEUTRAL RANGE)

▲ #2 Bullish Driver: Cash Engine Quality+9/20 pts (23% of score)

SEC XBRL FY 2025 (10-K): 9.6% FCF Margin ($64.5M FCF) & 23% Gross Margin

▼ #1 Drag / Risk Factor: SEC 10-K Forensic Risk5/20 pts (-15 pt drag)

Balance-sheet & 10-K footnote risk deducts 15 pts from forensic ceiling

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$6.61-0.6% Next Q

Q2 (-2Q)

Grade D$6.57-0.8% Next Q

Q3 (-1Q)

Grade D$6.52-2.5% Next Q

Current

Grade D-$6.36-7.4% Hist 90D α

Trajectory: D (48) → D- (40)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a GENI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While GENI currently carries a cautious 40/100 (D-) rating due to SEC 10-K Forensic Risk (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($6.63) and Max Pain ($6.68) forces dealer call-delta covering toward $12.15.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.12% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $GENI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “GENI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 40%NO 60%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

50.230 Oversold · 70 Hot

ALTMAN-Z SHIELDDISTRESS RISK (<1.8)

1.43>3.0 Fortress Safe

PIOTROSKI F-SCORESOLID CORE (5–6)

5 / 99-Pt Accounting

52-WEEK LASER RANGE33% OF RANGE

L: $4$6.36H: $12

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: DRQD 9 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: D-RQD 16 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: D-RQD 15 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on GENI

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (45)

-26.9% ROIC with 23.0% gross margin and 3.73% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BEARISH (25)

Altman-Z 1.43 and Piotroski 5/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (43)

16/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like GENI

✓Established market leader in Consumer Discretionary with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring GENI)

✓Walkthrough of GENI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

GENI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +41.33%⚡ TESTING RESISTANCE

2026-11-02O $6.35H $6.46L $6.35C $6.36VOL 5.22M

RES: $6.67SUP: $5.17SMA50: $6.63SMA200: $6.22

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

GENI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 GENI Butterfly Map → + Track GENI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +31.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on GENI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for GENI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for GENI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (GENI)

Consumer Discretionary Rank #734 of 1011 ⚔️ BRSL vs GENI Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (GENI vs. BRSL, PRSU, PRKS, STUB)

Industry: Services-Misc. Amusement & Recreation (51 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Genius Sports Limited (GENI) ranks #734 by composite RQD confidence (40/100, grade D-) and #436 by equity capitalization ($1.73B). Within this direct 5-issuer industry benchmark cohort, PRKS leads on earnings valuation at 8.5x trailing P/E, while PRKS leads on capital efficiency and profitability with 17.2% ROIC and — gross margin. PRSU currently holds the highest overall quantitative score in the immediate peer group at 53/100 (D+) compared with GENI at 40/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
GENI ACTIVE Genius Sports Limited	D-	40/100	—	23.0%	-26.9%	-1.55%	$1.73B	Benchmark Subject
BRSL Brightstar Lottery PLC Trading under the Legal Name to begin at the market open on July 21 2025.	E	34/100	12.0x	—	16.8%	+0.52%	$1.77B	/brsl-vs-geni →
PRSU Pursuit Attractions and Hospitality Inc.	D+	53/100	66.4x	92.3%	3.9%	-0.23%	$1.51B	/prsu-vs-geni →
PRKS United Parks & Resorts Inc.	D	48/100	8.5x	—	17.2%	-2.56%	$1.43B	/prks-vs-geni →
STUB StubHub Holdings Inc. (Class A)	D-	38/100	—	—	-35.0%	-0.69%	$2.22B	/stub-vs-geni →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001834489

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Genius Sports Limited (GENI) reported GAAP revenue of $669.5M (+31.0% vs. FY2024 revenue of $510.9M , and +62.1% cumulative change since FY2023) , GAAP net income of -$111.6M, operating cash flow of $86.4M, and free cash flow of $64.5M (-7.2% YoY). On the balance sheet, GENI closed FY2025 with $1.13B in total assets against $0 in total debt (Altman Z-Score: 1.43, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$669.5M	-$111.6M	$86.4M	$64.5M	$1.13B	—
FY2024 (FY)	2024-12-31	$510.9M	-$63.0M	$81.9M	$69.6M	$792.3M	—
FY2023 (FY)	2023-12-31	$413.0M	-$85.5M	$14.9M	$14.9M	—	—

3. GENI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is GENI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does GENI compare to BRSL and PRSU in the Consumer Discretionary sector?

What are the biggest fundamental strengths and SEC risk factors for GENI?

Where is GENI trading relative to its 50-day, 200-day, and 52-week technical levels?

GENI last traded at $6.36 (-1.55% on volume of 7,432,500 shares), positioning the stock -4.07% below its 50-day simple moving average ($6.63) and +2.25% above its 200-day simple moving average ($6.22). Across its 52-week range of $3.83 to $11.57, GENI sits at the 32.7% percentile with a 14-day RSI of 50.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.3% ($5.58 to $7.14).

GENI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell GENI stock right now?

Genius Sports Limited (GENI) currently earns a Roarable Rating of D- (Sell — SELL) with 40/100 RQD Confidence. Stretched risk/reward at current multiples (-27% return on capital) under elevated 10-year interest-rate pressure.

What is GENI's 12-month price target and RQD AI Jury consensus?

GENI's 12-month base price target is $5.84 (range $4.56 to $12.15), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: GENI RQD Cockpit GENI 12M Forecast GENI Earnings & Move GENI Dividends & DRIP GENI Insiders & 13F GENI Whale Options GENI Profit Sankey GENI News & Why

ROARABLE RATING BRIEF • RQD 40/100 (D-) ✓ STAGE-C NUMBER FIREWALL VERIFIED

GENI — Genius Sports Limited: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:27:56Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, GENI scores 40 out of 100 with a letter grade of D- and the verdict label "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars are:

Fundamental Cash Engine: 9 / 20. Per the Roarable RQD rating, this pillar reflects ROIC of -26.9% and an FCF yield of 3.73%. For a prospective investor, a negative ROIC means the business is not currently earning returns above its capital base, while a positive FCF yield indicates some cash generation relative to market value. These two facts pull in opposite directions, and the lower pillar score reflects the weight given to the return deficit.
Whale / 13F Flow: 8 / 20. Per the Roarable RQD rating, this pillar covers institutional accumulation and options positioning. The score is below midpoint, suggesting that institutional flow evidence is not a strong supporting factor for the stock at this time. Detailed holder-level data is not available in source data.
Insider Conviction: 8 / 20. Per the Roarable RQD rating, this pillar covers SEC Form 4 and Congressional PTR cluster flow. The score is below midpoint. Individual transaction detail is not available in source data.
Macro Regime Fit: 10 / 20. Per the Roarable RQD rating, beta is 1.0 and the pillar reflects sector sensitivity. A beta of 1.0 implies the stock is expected to move in line with the broader market, offering neither a defensive nor an amplified profile on that measure alone.
Forensic Balance Sheet: 5 / 20. Per the Roarable RQD rating, this pillar reflects Altman Z 1.43, Piotroski F 5/9, and Debt/Equity 0.5. This is the lowest-scoring pillar. An Altman Z of 1.43 and a Piotroski F of 5 out of 9 are the figures most directly tied to the "Vulnerable Balance Sheet" verdict.

Implications for a prospective investor: The upside case rests on the positive FCF yield and the recent price move in the market data, while the valuation and balance-sheet tradeoffs weigh heavily against it. Because earnings-based valuation metrics (P/E, EV/EBITDA, EPS) are not available in source data, the investor cannot benchmark the current price against earnings. The 52-week range of $3.83 - $11.57 against a current price of 6.46 shows the stock has moved substantially within the past year, which reflects elevated volatility relative to its own history.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$669.5M	$-151.3M	$-111.6M	N/A	$64.5M	$280.6M	N/A
FY 2024	$510.9M	$-58.5M	$-63.0M	N/A	$69.6M	$110.2M	N/A
FY 2023	$413.0M	$-74.2M	$-85.5M	N/A	$14.9M	N/A	N/A

Per the SEC financials, revenue rose from $413.0M in FY 2023 to $669.5M in FY 2025, while operating and net losses persisted across all three periods. Per the market data, gross margin is 23%, operating margin is -22.6%, and net margin is -16.7%, with ROIC of -26.9%. Per the Roarable RQD rating, the Altman Z-Score is 1.43, the Piotroski F-Score is 5/9, and Debt/Equity is 0.5. Reported cash increased from $110.2M in FY 2024 to $280.6M in FY 2025, while reported FCF was $64.5M in FY 2025.

Recent Catalysts & News Wire Analysis

Per the recent news and catalysts feed, the headlines are dominated by general market-wire coverage rather than company-specific operating events:

Yellow (Market Wire): A Yahoo Finance Singapore profile of GENI, a Simply Wall St forecast and analyst predictions page, a MarketBeat report noting a consensus target price, and a Stock Titan item on an X NFL data feed. These are informational items without a stated operating outcome.
Red (Risk Watch): A Stock Traders Daily item on risk zones for GENI, flagged as a risk-watch signal.
Green (Catalyst): A MarketBeat report that Zacks Research raised its rating on GENI to Hold.

Per the Butterfly Supply-Chain Graph, the sector is Consumer Discretionary, the supply chain is listed as NONE, and no butterfly links or proprietary signals are provided.

Open Questions

What are GENI's P/E, forward P/E, EV/EBITDA, and EPS, so the current price can be benchmarked against earnings?
What is the reported debt balance, since the financials show debt as N/A for all periods while Debt/Equity is cited at 0.5?
What is the FY 2023 cash balance, which is listed as N/A in the reported financials?
Which institutional holders and insider transactions drive the whale and insider pillar scores?
What operating drivers explain the revenue growth from FY 2023 to FY 2025 alongside persistent operating losses?

GENI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Genius Sports Limited (GENI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to GENI Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance Singapore • 11h ago

Genius Sports Limited (GENI) stock price, news, quote and history

Yahoo Finance Singapore report covering Genius Sports Limited (GENI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Simply Wall St • 14h ago

Genius Sports (NYSE:GENI) Stock Forecast & Analyst Predictions

Simply Wall St report covering Genius Sports Limited (GENI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 17h ago

Genius Sports Limited (NYSE:GENI) Stock Has Consensus Target Price of $11.25

MarketBeat report covering Genius Sports Limited (GENI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 20h ago

X's NFL feed pairs official scores with clips and creator commentary

Stock Titan report covering Genius Sports Limited (GENI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Stock Traders Daily • 23h ago

Precision Trading with Genius Sports Limited (GENI) Risk Zones

Stock Traders Daily report covering Genius Sports Limited (GENI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST MarketBeat • 1d ago

Genius Sports (NYSE:GENI) Stock Rating Raised to Hold at Zacks Research

MarketBeat report covering Genius Sports Limited (GENI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Kalkine Media • 1d ago

Can Genius Sports (NYSE:GENI) Expand Its Nasdaq Composite Reach?

Kalkine Media report covering Genius Sports Limited (GENI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 1d ago

Offside decisions took over 30% less time on average across major competitions using Genius Sports' system.

Stock Titan report covering Genius Sports Limited (GENI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

GENI Bull vs. Bear Conversation Board — What's Your Call at $6.36?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON GENI 🐻 67% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $5.68 (-12.1%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is GENI (D- • RQD 40/100) a Buy at $6.46?

Welcome to the GENI (Genius Sports Limited) Roar Pit. Current RQD Composite is 40/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Services-Misc. Amusement & Recreation. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

RI RiskArb_Desk Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $5.30 (-18.0%)

Spot @ $6.46

Pump the brakes on GENI — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on GENI, but look at what you are paying: current EV/EBITDA multiples with 23.0% gross margins. Unless Genius Sports Limited expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

AL AlphaFlow_Cap Verified K Arena Trader 🐂 BULLISH 🎯 Target: $8.14 (+26.0%)

Spot @ $6.46

GENI cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on GENI, the market is fixating on short-term headline noise in Services-Misc. Amusement & Recreation and ignoring the balance sheet and cash flow trajectory. At $6.46 (52-wk range $3.83 - $11.57), any beat on forward guidance forces shorts and underweight funds to chase.